MDT
95.62
+0.66%↑
VEEV
283
-3.27%↓
A
141.9
+0.66%↑
HQY
91.19
+0.35%↑
TLRY
1.55
+1.31%↑
MDT
95.62
+0.66%↑
VEEV
283
-3.27%↓
A
141.9
+0.66%↑
HQY
91.19
+0.35%↑
TLRY
1.55
+1.31%↑
MDT
95.62
+0.66%↑
VEEV
283
-3.27%↓
A
141.9
+0.66%↑
HQY
91.19
+0.35%↑
TLRY
1.55
+1.31%↑
MDT
95.62
+0.66%↑
VEEV
283
-3.27%↓
A
141.9
+0.66%↑
HQY
91.19
+0.35%↑
TLRY
1.55
+1.31%↑
MDT
95.62
+0.66%↑
VEEV
283
-3.27%↓
A
141.9
+0.66%↑
HQY
91.19
+0.35%↑
TLRY
1.55
+1.31%↑
24h
Praegune
Min
2.65
Max
2.75
Soovitused | Osta |
---|---|
12 kuu keskmine prognoos | +429.2% upside |
Järgmine tulemuste avaldamine | 12. nov 2025 |
---|
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
1. okt 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Loe
10. märts 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Loe
10. märts 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Loe
10. märts 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Loe
10. märts 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Loe
10. märts 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Loe
10. märts 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Loe
10. märts 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Loe
Hinnamuutus
By TipRanks
12 kuu keskmine prognoos
Keskmine 14.5 USD 429.2%
Kõrge 17 USD
Madal 12 USD
Põhineb 2 Wall Streeti analüütiku instrumendi Fortress Biotech Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
By TipRanks
Osta
2 ratings
2
Osta
0
Hoia
0
Müü
Põhineb 2 analüütiku instrumendi Fortress Biotech Inc aktsia reitingul - viimase 3 kuu andmed.
$